 BEIJING, Oct. 29, 2020 GLOBE NEWSWIRE -- Genetron Holdings Limited Genetron Health or the Company, Nasdaq: GTH, a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that management will present and host 1x1 investor meetings at six upcoming investor and industry conferences. 